These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 12522559

  • 1. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B, Rodríguez-Perales S, Martínez-Delgado B, Otero I, Robledo M, Martínez-Ramírez A, Ruiz-Llorente S, Urioste M, Cigudosa JC, Benítez J.
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER.
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [Abstract] [Full Text] [Related]

  • 3. Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.
    Kanayama H, Lui WO, Takahashi M, Naroda T, Kedra D, Wong FK, Kuroki Y, Nakahori Y, Larsson C, Kagawa S, Teh BT.
    J Med Genet; 2001 Mar; 38(3):165-70. PubMed ID: 11238683
    [Abstract] [Full Text] [Related]

  • 4. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.
    Cancer Res; 2001 Oct 01; 61(19):7277-81. PubMed ID: 11585766
    [Abstract] [Full Text] [Related]

  • 5. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
    Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA.
    Hum Mol Genet; 1994 Dec 01; 3(12):2169-73. PubMed ID: 7881415
    [Abstract] [Full Text] [Related]

  • 6. About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p14.1;q24.23) family.
    Valle L, Cascón A, Melchor L, Otero I, Rodríguez-Perales S, Sánchez L, Cruz Cigudosa J, Robledo M, Weber B, Urioste M, Benítez J.
    Eur J Hum Genet; 2005 May 01; 13(5):570-8. PubMed ID: 15756303
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB, Amare Kadam PS.
    Urol Oncol; 2013 Oct 01; 31(7):1333-42. PubMed ID: 21962529
    [Abstract] [Full Text] [Related]

  • 10. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K, Al-Saleem T, Karbowniczek M, Ewalt D, Prowse AH, Henske EP.
    Mod Pathol; 2002 Mar 01; 15(3):205-10. PubMed ID: 11904337
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3)(q35;q21).
    Bodmer D, Eleveld M, Ligtenberg M, Weterman M, van der Meijden A, Koolen M, Hulsbergen-van der Kaa C, Smits A, Smeets D, Geurts van Kessel A.
    Cancer Genet Cytogenet; 2002 Apr 01; 134(1):6-12. PubMed ID: 11996788
    [Abstract] [Full Text] [Related]

  • 13. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.
    Martinez A, Fullwood P, Kondo K, Kishida T, Yao M, Maher ER, Latif F.
    Mol Pathol; 2000 Jun 01; 53(3):137-44. PubMed ID: 10897333
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt S, Walther M, Linehan WM, Klausner RD, Ried T.
    Genes Chromosomes Cancer; 2001 May 01; 31(1):1-9. PubMed ID: 11284029
    [Abstract] [Full Text] [Related]

  • 16. [Analysis of biallelic inactivation of the von Hippel-Lindau tumor suppressor gene VHL in patients of renal cell carcinoma patient].
    Liu N, Gong K, Zhang N, Guo HF, Na X, Wu G, Na YQ.
    Zhonghua Wai Ke Za Zhi; 2005 Jan 15; 43(2):115-7. PubMed ID: 15771820
    [Abstract] [Full Text] [Related]

  • 17. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M, Yao M, Ishikawa I, Kishida T, Nagashima Y, Kondo K, Nakaigawa N, Hosaka M.
    Genes Chromosomes Cancer; 2002 Dec 15; 35(4):359-64. PubMed ID: 12378530
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC, Walsh S, Hewson K, Green EK, Brinke A, Green PM, Gianelli F, Eng C, Maher ER.
    Genes Chromosomes Cancer; 1999 Sep 15; 26(1):20-8. PubMed ID: 10441001
    [Abstract] [Full Text] [Related]

  • 20. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B.
    Cancer Surv; 1995 Sep 15; 25():219-32. PubMed ID: 8718521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.